Problems with classification of polineuropaties severity in case of hereditary ones – review of literature
DOI:
https://doi.org/10.12775/JEHS.2023.13.04.034Keywords
polyneuropathy, Charcot-Marie-Tooth neuropathy, nerve conduction studiesAbstract
Evaluation of neuropathy severity is still a challenge for a modern medicine. Many scales were made to resolve this problem but each of them has limitations. It is known that in case of many patients there is no relation between clinical status and nerve conduction studies (NCS) results. Severe disabled patients with neuropathies can have nerve conduction study result mild impaired and conversely relation is also often observed. Many screening instruments with numerous composite scores are used to evaluate neuropathy. Most of them involved sensory perception, motor functions and reflexes like Neuropathy Disability Score (NDS), Neuropathy Impairment Score (NIS), Thoronto Clinical Neuropathy Scoring System. Electrophysiological parameters are also useful in classification of disease types especially in Charcot-Marie-Tooth one. There were many attempts of discovering new scores especially in diabetic neuropathies, involving mainly clinical features. There is lack of easy, reliable and precise scores that could improve neuropathy classification and monitoring disease progression especially in case of hereditary polyneuropathy.
References
Service F., Rizza R., Daube J. et al.: Near normoglycaemia improved nerve conduction and vibration sensation in diabetic neuropathy. Diab. 1985;28:722–7.
Dyck P., Davies J., Daube J. et al.: Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort. Neurology. 1997;49:229–39.
Bril V., Perkins B.: Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy. Diabetes Care. 2002;25:2048–52.
Andreja P., Neli R., Ortega R. et al.: Classification of the severity of diabetic neuropathy: a new approach taking uncertainties into account using fuzzy logic. Clinics. 2012; 67:151–156.
Valk G., de Sonnaville J., van Houtum W. et al.: The assessment of diabetic polyneuropathy in daily clinical practice: reproducibility and validity of Semmes Weinstein monofilaments examination and clinical neurological examination. Muscle Nerve. 1997;20:116–8.
Poll-Franse L., Valk G., Renders C. et al.: Longitudinal assessment of the development of diabetic polyneuropathy and associated risk factors. Diabet Med. 2002;19:771–6.
Pareyson D., Marchesi Ch.: Diagnosis, natural history, and management of Charcot-Marie-Tooth disease. The Lancet Neurology. 2009: 8;654-67.
Dyck P., Karnes J., Lambert E.: Longitudinal study of neuropathic deficits and nerve conduction abnormalities in hereditary motor and sensory neuropathy type 1. Neurology 1989; 39: 130-138.
Killian J., Tiwari P., Jacobson S. et al.: Longitudinal studies of the duplication form of Charcot-Marie-Tooth polyneuropathy. Muscle Nerve 1996; 19: 74-78.
Garcia A., Combarros O., Calleja J. et al.: Charcot-Marie-Tooth disease type 1A with 17p duplication in infancy and early childhood: a longitudinal clinical and electrophysiologic study. Neurology 1998; 50: 1061-67.
Berciano J., García A., Combarros O.: Initial semeiology in children with Charcot-Marie-Tooth disease 1A duplication. Muscle Nerve 2003; 27: 34-39.
Yiu E., Burns J., Ryan M et al.: Neurophysiologic abnormalities in children with Charcot-Marie-Tooth disease type 1A. J Peripher Nerv Syst 2008; 13: 236-41.
Krajewski K., Lewis R., Fuerst D et al.: Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A. Brain 2000; 123: 1516-27.
Gherardi R., Bouche P., Escourolle R. et al.: Peroneal muscular atrophy. Nervebiopsy studies. J. Neurol. Sci. 1983; 61:401–416.
Krajewski K., Lewis R., Fuerst D. et al.: Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A. Brain 2000;123: 1516-27.
Siskind C., Panchal S., Smith C et al.: Review of Genetic Counseling for Charcot Marie Tooth Disease (CMT). J Genet Counsel 2013; 22:422–436.
Bienfait, H., Verhamme C., van Schaik I. et al.: Comparison of CMT1A and CMT2: similarities and differences. Journal of Neurology 2006; 253:1572–1580.
Berciano J., Garcı´a A., Combarros O. et al.: Initial semeiology in children with Charcot–Marie-Tooth disease. Muscle Nerve 2003; 27:34–39.
Garcia C., Malamut R., England J. et al.: Clinical variability in two pairs of identical twins with the Charcot-Marie-Tooth disease type 1A duplication. Neurology 1995;45:2090–2093.
Lewis R., Sumner A., Shy M.: Electrophysiological features of inherited demyelinating neuropathies: A reappraisal in the era of molecular diagnosis. Muscle Nerve 2000; 23, 1472–1487.
Sghirlanzoni A., Pareyson D., Scaioli V. et al.: Hereditary motor and sensory neuropathy type I and II. Ital. J. Neurol. Sci. 1990;11: 471–479.
Scaioli V., Pareyson D., Avanzini G. et al.: F response and somatosensory and brainstem auditory evoked potential studies in HMSN type I and II. J. Neurol. Neurosurg. Psychiatry 1992; 55:1027–1031.
Andersen H., Stålberg E., Falck B.: F-wave latency, the most sensitive nerve conduction parameter in patients with diabetes mellitus. Muscle Nerve. 1997;20:1296-302.
1st Keypoint®Net Course Stalberg S.: Keypoint Classic Database tool and Keypoint Net Strategies Uppsala, Sweden, May 27-29, 2015
Shy M., Blake J., Krajewski K. et al.: Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology 2005; 64:1209– 1214.
Sadjadi R., Reilly M., Shy M. et al.: Psychometrics evaluation of Charcot-Marie-Tooth Neuropathy Score (CMTNSv2) second version, using Rasch analysis. J Peripher Nerv Syst. 2014 ;19: 192–196.
Pareyson D., Reilly M., Schenone A. et al.: CMT- TRIAAL; CMT-TRAUK groups. Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial. Lancet Neurology. 2011; 10:320– 328.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Jakub Stępień, Żanna Pastuszak
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 265
Number of citations: 0
